These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15601626)

  • 21. Establishment of robust functional assays for the characterization of neuropeptide Y (NPY) receptors: identification of 3-(5-benzoyl-thiazol-2-ylamino)-benzonitrile as selective NPY type 5 receptor antagonist.
    Dautzenberg FM; Higelin J; Pflieger P; Neidhart W; Guba W
    Neuropharmacology; 2005 Jun; 48(7):1043-55. PubMed ID: 15857631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.
    Weiss S; Keller M; Bernhardt G; Buschauer A; König B
    Bioorg Med Chem; 2008 Nov; 16(22):9858-66. PubMed ID: 18851917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of new hydrazide derivatives as neuropeptide Y Y5 receptor antagonists for the treatment of obesity.
    Juanenea L; Galiano S; Erviti O; Moreno A; Pérez S; Aldana I; Monge A
    Bioorg Med Chem; 2004 Sep; 12(17):4717-23. PubMed ID: 15358298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloning and functional expression of the hNPY Y5 receptor in human endometrial cancer (HEC-1B) cells.
    Moser C; Bernhardt G; Michel J; Schwarz H; Buschauer A
    Can J Physiol Pharmacol; 2000 Feb; 78(2):134-42. PubMed ID: 10737676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns of promoters for NPY Y(1) and Y(5) receptors in Y(5)RitTA and Y(1)RVenus BAC-transgenic mice.
    Oberto A; Acquadro E; Bus T; Sprengel R; Eva C
    Eur J Neurosci; 2007 Jul; 26(1):155-70. PubMed ID: 17614946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of protease activated receptor-1 by a serum responsive element-dependent reporter gene assay: major role of calmodulin.
    De Vries L; Palmier C; Finana F; Le Grand B; Perez M; Cussac D
    Biochem Pharmacol; 2006 May; 71(10):1449-58. PubMed ID: 16524561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel potent neuropeptide Y Y5 receptor antagonists: synthesis and structure-activity relationships of phenylpiperazine derivatives.
    Takahashi T; Sakuraba A; Hirohashi T; Shibata T; Hirose M; Haga Y; Nonoshita K; Kanno T; Ito J; Iwaasa H; Kanatani A; Fukami T; Sato N
    Bioorg Med Chem; 2006 Nov; 14(22):7501-11. PubMed ID: 16919461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function.
    Cox HM
    Auton Neurosci; 2007 Apr; 133(1):76-85. PubMed ID: 17140858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationships of trisubstituted phenyl urea derivatives as neuropeptide Y5 receptor antagonists.
    Fotsch C; Sonnenberg JD; Chen N; Hale C; Karbon W; Norman MH
    J Med Chem; 2001 Jul; 44(14):2344-56. PubMed ID: 11428928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A simple and powerful flow cytometric method for the simultaneous determination of multiple parameters at G protein-coupled receptor subtypes.
    Schneider E; Mayer M; Ziemek R; Li L; Hutzler C; Bernhardt G; Buschauer A
    Chembiochem; 2006 Sep; 7(9):1400-9. PubMed ID: 16888730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors.
    Deswal S; Roy N
    Eur J Med Chem; 2007 Apr; 42(4):463-70. PubMed ID: 17083999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of new benzoxazinone derivatives as neuropeptide Y5 antagonists for the treatment of obesity.
    Torrens A; Mas J; Port A; Castrillo JA; Sanfeliu O; Guitart X; Dordal A; Romero G; Fisas MA; Sánchez E; Hernández E; Pérez P; Pérez R; Buschmann H
    J Med Chem; 2005 Mar; 48(6):2080-92. PubMed ID: 15771450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of human dopamine D1-like receptor agonist using a cell-based functional assay.
    Jiang N; Ou-Yang KQ; Cai SX; Hu YH; Xu ZL
    Acta Pharmacol Sin; 2005 Oct; 26(10):1181-6. PubMed ID: 16174433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of neuropeptide Y on food intake and brain biogenic amines in the rainbow trout (Oncorhynchus mykiss).
    Aldegunde M; Mancebo M
    Peptides; 2006 Apr; 27(4):719-27. PubMed ID: 16253390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and characterization of rabbit neuropeptide Y receptor subtypes.
    Umeda T; Kanatani A; Iwaasa H
    Peptides; 2009 Aug; 30(8):1441-7. PubMed ID: 19481128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
    Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
    Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
    Tu B; Jiao Y; Herzog H; Nadler JV
    Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biophysical methods to study ligand-receptor interactions of neuropeptide Y.
    Bettio A; Beck-Sickinger AG
    Biopolymers; 2001; 60(6):420-37. PubMed ID: 12209475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and characterization of the first fluorescent nonpeptide NPY Y1 receptor antagonist.
    Schneider E; Keller M; Brennauer A; Hoefelschweiger BK; Gross D; Wolfbeis OS; Bernhardt G; Buschauer A
    Chembiochem; 2007 Nov; 8(16):1981-8. PubMed ID: 17876753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.